Security file · CUSIP G4766E116
Indivior Pharmaceuticals Inc
Indivior Pharmaceuticals Inc · held by 1 tracked manager in Q4 2025.
Tracked holders · Q4 2025
1
+0 vs Q3 2025
Aggregate reported value
$255M
sum of holders' reported positions
New holders this quarter
0
0 added · 1 trimmed
Holder return since filing
—
weighted by each holder's position share · since filing
Ownership · Q4 2025
| Manager | Weight | Shares | Δ shares | Entry | Return | Value | Activity | |
|---|---|---|---|---|---|---|---|---|
| 1 | Howard Marks - Oaktree Capital Managementfiled 17 Feb ET | 3.63% | 7.11M | -97.2% | — | — | $255M | Trimmed |
Holder count
Aggregate reported value
Quarterly aggregation
| Quarter | Holders | Δ holders | Aggregate value | Total shares |
|---|---|---|---|---|
| Q4 2025 | 1 | +0 | $255M | 7.11M |
| Q3 2025 | 1 | +0 | $10.69M | 257.79M |
| Q2 2025 | 1 | +0 | $162M | 11.01M |
| Q4 2024 | 1 | +0 | $112M | 8.73M |
| Q3 2024 | 1 | +0 | $94.07M | 9.52M |
| Q2 2024 | 1 | — | $70.43M | 4.49M |